Treatment Options for Rheumatoid Disease: A Comparison of Biological Therapies and DMARDs

Rheumatoid disease can be a debilitating condition that requires careful management. When standard disease-modifying anti-rheumatic drugs (DMARDs) fail to provide relief, biological therapies may be prescribed. Infliximab, adalimumab, and etanercept are some of the contemporary biological therapies available. Infliximab, in particular, is often co-prescribed with methotrexate, although it may cause a reversible lupus-like syndrome and tuberculosis reactivation.

Combining gold, leflunomide, and methotrexate is unlikely to help patients who have already failed DMARD therapy. Azathioprine may be considered in severe cases, but biological therapy is the preferred treatment when intensive DMARD therapy fails. The combination of gold and penicillamine is a viable option for patients who meet the criteria for biological therapy, according to National Institute for Health and Care Excellence (NICE) guidelines. DMARD monotherapy, such as leflunomide, is only recommended when dual therapy is contraindicated.

In summary, the choice of treatment for rheumatoid disease depends on the severity of the condition and the patient’s response to previous therapies. Biological therapies may offer relief for patients who have failed DMARD therapy, but careful monitoring for potential side effects is necessary.

Acid-Base Disorders and Differential Diagnosis of Granulomatosis with Polyangiitis

In cases of metabolic acidosis with respiratory compensation, the primary issue is a decrease in bicarbonate levels and pH, which is accompanied by a compensatory decrease in pCO2. On the other hand, respiratory acidosis with metabolic compensation is characterized by an increase in pCO2 and a decrease in pH, which is accompanied by a compensatory increase in bicarbonate levels.

When nosebleeds are present, the diagnosis of Granulomatosis with polyangiitis is more likely than microscopic polyarteritis due to upper respiratory tract involvement. Goodpasture’s disease is less likely because it does not cause a rash. In particular, 95% of patients with Granulomatosis with polyangiitis develop antineutrophil cytoplasmic antibodies (cytoplasmic pattern) or cANCAs, with proteinase-3 being the major c-ANCA antigen. Conversely, perinuclear or p-ANCAs are directed against myeloperoxidase, are non-specific, and are detected in various autoimmune disorders.

Migratory tenosynovitis can be caused by disseminated gonococcal infection in younger adults, particularly women. It is important to test for C6-C9 complement deficiency. Rheumatoid arthritis can also cause tenosynovitis, but it is not migratory and is usually found in the interphalangeal, metacarpophalangeal, and wrist joints. Scleroderma can cause tenosynovitis, but it is not migratory either. Fluoroquinolone toxicity may increase the risk of tendinopathy and tendon rupture, but it does not cause migratory tenosynovitis. Reactive arthritis can cause tendinitis, but it is more prevalent in men and is not migratory. It is a rheumatoid factor-seronegative arthritis that can be linked with HLA-B27.

Differential Diagnosis for a Patient with Splenomegaly, Neutropenia, and Active Rheumatoid Disease

Felty’s Syndrome:
The patient’s symptoms of splenomegaly, neutropenia, and active rheumatoid disease suggest Felty’s syndrome. This condition is thought to occur due to the sequestration and destruction of granulocytes, potentially caused by reduced granulocyte growth factors and autoantibodies/immune complexes formed against them. Felty’s syndrome affects 1-3% of patients with rheumatoid arthritis and has a higher prevalence in females. Treatment typically involves the use of methotrexate as a disease-modifying anti-rheumatic drug, with splenectomy reserved as a last resort.

Lymphoma:
While lymphoma can present with lymphadenopathy, the absence of B-symptoms such as fever, night sweats, weight loss, or pruritus makes this diagnosis less likely in this case.

Myeloma:
Myeloma often presents with anaemia and bone pain, as well as hypercalcaemia. Serum and urine electrophoresis are important investigations for this condition.

Sarcoidosis:
Sarcoidosis commonly presents with respiratory symptoms such as wheeze, cough, and shortness of breath, as well as erythema nodosum and lymphadenopathy on examination. While the patient has a history of lower respiratory tract infections, her response to clarithromycin suggests an infective cause rather than sarcoidosis.

Tuberculosis:
The patient does not have any clinical features or risk factors for tuberculosis.

Heberden’s Nodules

Heberden’s nodules are bony growths that form around the joints at the end of the fingers. These nodules are most commonly found on the second and third fingers and are caused by calcification of the cartilage in the joint. This condition is often associated with osteoarthritis and is more common in women. Heberden’s nodules typically develop in middle age.

Overall, Heberden’s nodules can be a painful and uncomfortable condition for those who experience them. However, the causes and symptoms of this condition can help individuals seek appropriate treatment and manage their symptoms effectively. With proper care and attention, it is possible to minimize the impact of Heberden’s nodules on daily life.

Autoantibodies and their Associated Diseases

Autoantibodies are antibodies produced by the immune system that mistakenly target and attack the body’s own tissues. Here are some common autoantibodies and the diseases they are associated with:

1. c-ANCA (antineutrophil cytoplasmic antibody): GPA, a necrotising small-vessel vasculitis that commonly affects the kidneys and lungs.

2. Antimitochondrial antibody: primary biliary cholangitis.

3. Anti Glomerular basement membrane antibody: Goodpasture’s syndrome, a rare autoimmune disease that affects the lungs and kidneys.

4. p-ANCA (perinuclear ANCA): Eosinophilic Granulomatosis with Polyangiitis (previously known as Churg–Strauss syndrome), a rare autoimmune disease that affects the blood vessels.

5. Anti-acetylcholine receptor antibody: myasthenia gravis, a neuromuscular disorder that causes muscle weakness and fatigue.

Understanding the association between autoantibodies and their associated diseases can aid in diagnosis and treatment.

The symptoms described suggest a diagnosis of ankylosing spondylitis, a chronic form of seronegative spondyloarthropathy that primarily affects the axial skeleton. Diagnosis is made using the modified New York criteria, which includes clinical and radiological criteria. HLA-B27 and sacroiliitis on MRI play a major role in the recently proposed ASAS diagnostic algorithm. Radiographic sacroiliitis is required for eligibility for anti-TNF treatment. Other conditions, such as pseudogout, Lyme disease, osteoarthritis, and rheumatoid arthritis, are unlikely diagnoses. Timely diagnosis requires a high index of suspicion.

Diagnosing Prepatellar Bursitis: Understanding Joint Aspirate Results

Prepatellar bursitis, also known as housemaid’s knee, is a common condition caused by inflammation of the prepatellar bursa. This can result from repetitive microtrauma, such as prolonged kneeling. Patients typically present with localised, mildly tender swelling over the patella, which can be warm but not hot. Aspiration of the aseptic bursa will reveal a clear and/or milky aspirate that has negative Gram staining and normal microscopy.

When examining joint aspirate results, it is important to consider other potential diagnoses. Gram-positive cocci, for example, would be grown in the case of Staphylococcus aureus infection, a common cause of septic bursitis. However, in the absence of fever, erythema, and reduced range of motion, septic arthritis is unlikely. Similarly, needle-shaped crystals with strong negative birefringence on polarised light microscopy are seen in gout, but this condition typically presents with acute pain, redness, and inflammation.

Rhomboid-shaped crystals with weak positive birefringence on polarised light microscopy are seen in pseudogout, which can affect the knee. However, this condition typically affects the entire knee joint and is more common in the elderly.

In summary, a clear or milky joint aspirate with normal microscopy and culture is consistent with prepatellar bursitis. Other potential diagnoses should be considered based on the patient’s history and examination findings.

The Importance of Pre-Operative Testing for a Patient with Rheumatoid Arthritis

Patients with rheumatoid arthritis (RA) require special considerations before undergoing elective surgery. One important test to consider is a cervical spine X-ray, as RA can lead to subluxation and instability in the cervical spine. This is particularly important for patients who will be intubated during surgery, as neck manipulation can exacerbate any underlying instability.

Another important consideration for RA patients is regular eye exams to test for retinal toxicity, especially for those taking hydroxychloroquine as part of their treatment regimen. However, this is not necessarily required before elective surgery.

While rheumatoid factor levels and anti-citrullinated protein antibody levels can be elevated in RA patients, they are not the most important tests to consider before surgery. Instead, a plain film of the cervical spine should be the primary investigation for patients with a history of RA.

Overall, pre-operative testing for RA patients should be tailored to their specific needs and potential risks during surgery.

Understanding HLA and Autoimmune Diseases

HLA-B27 is a genetic marker associated with ankylosing spondylitis, an autoimmune disease that primarily affects the spine. This disease is more common in males and typically presents in the 20s and 30s. Other autoimmune manifestations, such as anterior uveitis, can also occur in individuals with HLA-B27. Additionally, young men with this genetic marker may be prone to reactive arthritis after chlamydia or gonorrhoeal urethritis.

Rheumatoid factor, on the other hand, is not associated with HLA-B27 or ankylosing spondylitis. While stiffness that improves with exercise may be seen in rheumatoid arthritis, this disease typically affects peripheral joints and does not lead to calcification of the anterior spinal ligament.

Other HLA markers are associated with different autoimmune diseases. HLA-DR3 is linked to type 1 diabetes mellitus, HLA-DR5 is associated with pernicious anaemia and Hashimoto’s thyroiditis, and HLA-B8 is linked to Graves’ disease. Understanding these genetic markers can aid in the diagnosis and management of autoimmune diseases.

The first-line treatment for ankylosing spondylitis is non-steroidal anti-inflammatories (NSAIDs) like ibuprofen, which should be used alongside physiotherapy and exercise. Long-term NSAID use requires gastro protection with a proton-pump inhibitor. If morning or night pain persists despite NSAIDs, a long-acting preparation can be tried. Tumour necrosis factor (TNF)-alpha inhibitors like etanercept are recommended for poorly controlled ankylosing spondylitis after NSAIDs. Methotrexate is only useful in cases with extensive peripheral joint involvement, which is not mentioned in the vignette. Oral steroids like prednisolone are not first-line management, but intra-articular corticosteroids may be considered for poorly controlled sacroiliitis. Sulfasalazine, a disease-modifying agent used in rheumatoid arthritis, is only useful in ankylosing spondylitis patients with peripheral joint involvement, which is not mentioned in the vignette.

Osteomalacia: Causes and Symptoms

Osteomalacia is a condition that occurs due to a deficiency of vitamin D. This condition can be caused by various factors such as malabsorption, renal disease, chronic renal failure, and anticonvulsant therapy. The most common symptom of osteomalacia is bone pain, which is often accompanied by a proximal myopathy. These symptoms are also known as Looser’s zones.

Malabsorption, which is the inability of the body to absorb nutrients from food, can lead to osteomalacia. Renal disease, such as familial hypophosphataemic rickets, can also cause this condition. Chronic renal failure, which is the gradual loss of kidney function, can also lead to osteomalacia. Additionally, anticonvulsant therapy, which is used to treat seizures, can cause a deficiency of vitamin D and lead to osteomalacia.

If you experience bone pain or a proximal myopathy, it is important to seek medical attention. A doctor can diagnose osteomalacia through blood tests and imaging studies. Treatment typically involves vitamin D and calcium supplements, as well as addressing the underlying cause of the deficiency. With proper treatment, the symptoms of osteomalacia can be managed and the condition can be prevented from worsening.

Understanding Gout and its Causes: A Review of Medications and Differential Diagnosis

Gout is a type of inflammatory arthritis caused by the deposition of urate crystals in the joint. This article reviews the causes of gout, which can be primary or secondary hyperuricaemia. Secondary hyperuricaemia can be caused by overproduction or decreased renal excretion, including the use of thiazide diuretics like bendroflumethiazide. The differential diagnosis for an acute red, hot swollen joint includes septic arthritis, gout, pseudogout, inflammatory monoarthritis, and post-traumatic causes. Treatment for gout includes medications for chronic and acute gout, such as non-steroidal anti-inflammatory drugs, colchicine, or prednisolone. This article also discusses the effects of medications like colchicine, propranolol, lisinopril, and moxonidine on gout and other conditions.

Common Hand and Wrist Pathologies

The hand and wrist are common sites of pathology, particularly in postmenopausal women. Osteoarthritis frequently affects the first carpometacarpal joint, causing tenderness, stiffness, crepitus, swelling, and pain on thumb abduction. This can lead to squaring of the hand, radial subluxation of the metacarpal, and atrophy of the thenar muscles.

Scaphoid fractures are also relatively common, often resulting from a fall onto an outstretched hand. The proximal portion of the scaphoid lacks its own blood supply, which can lead to avascular necrosis if a fracture isolates it from the rest of the bone. This produces pain and tenderness on the radial side of the wrist, typically in the anatomical snuffbox, worsened by wrist movement.

De Quervain’s tenosynovitis is another common pathology, characterized by stenosing tenosynovitis of the first dorsal compartment of the wrist. It presents with pain, swelling, and tenderness on the radial aspect of the wrist. Treatment typically involves splinting, with or without corticosteroid injection.

Diagnostic Markers for Polymyalgia Rheumatica and Temporal arthritis

Polymyalgia rheumatica and temporal arthritis are inflammatory conditions that can cause significant morbidity if left untreated. Here are some diagnostic markers that can help support or rule out these conditions:

Plasma viscosity: A raised plasma viscosity can support a diagnosis of polymyalgia rheumatica with temporal arthritis, but it is a nonspecific inflammatory marker.

Creatine kinase: A raised creatine kinase is not supportive of a diagnosis of polymyalgia rheumatica or temporal arthritis.

Monospot test: A positive monospot test is supportive of a diagnosis of Epstein–Barr virus (EBV), but not polymyalgia rheumatica or temporal arthritis.

Whole cell count (WCC): A raised WCC is not supportive of a diagnosis of polymyalgia rheumatica or temporal arthritis.

Bence Jones proteins: Presence of Bence Jones protein is supportive of a diagnosis of multiple myeloma, but not polymyalgia rheumatica or temporal arthritis.

If temporal arthritis is suspected, immediate treatment with prednisolone is crucial to prevent permanent loss of vision. A temporal artery biopsy can confirm the diagnosis.

Diagnosing Rheumatoid Arthritis: Differential Diagnosis

Rheumatoid arthritis is a common autoimmune disorder that affects the joints, causing morning stiffness and small joint polyarthritis. A positive rheumatoid factor is present in 70% of patients, while anti-CCP antibodies are highly specific for rheumatoid arthritis and can be useful in rheumatoid factor-negative cases.

Other conditions that may present with similar symptoms include systemic lupus erythematosus (SLE), antiphospholipid antibody syndrome, seronegative arthritis, and polymyalgia rheumatica. However, in this case, there are no other features to suggest SLE, one episode of deep vein thrombosis during pregnancy is insufficient to suggest antiphospholipid antibody syndrome, the patient is seropositive for rheumatoid factor ruling out seronegative arthritis, and there is no story of proximal muscle pain which could be suggestive of polymyalgia rheumatica. Therefore, the diagnosis of rheumatoid arthritis is most likely.

Systemic lupus erythematosus (SLE) is an autoimmune disease that primarily affects young women. It is caused by the deposition of immune complexes and can have a wide range of clinical effects, including a butterfly-shaped rash on the cheeks and nose, joint pain, and involvement of multiple organ systems such as the kidneys, lungs, and heart. SLE is associated with the presence of ANA and dsDNA antibodies, as well as low levels of C3 and C4 in the blood.

Mixed connective tissue disease (MCTD) is a syndrome that shares features with several other rheumatological conditions, including SLE, scleroderma, myositis, and rheumatoid arthritis. Common symptoms include fatigue, joint pain, pulmonary involvement, and Raynaud’s phenomenon. MCTD is strongly associated with anti-RNP antibodies.

Rheumatoid arthritis is an inflammatory arthritis that typically affects middle-aged women and causes symmetrical joint pain and stiffness, particularly in the hands and feet. If left untreated, it can lead to deformities that affect function. Rheumatoid arthritis is associated with the presence of autoantibodies such as rheumatoid factor and anti-CCP.

Polymyositis is an autoimmune myositis that causes weakness and loss of muscle mass, particularly in the proximal muscles. Other symptoms may include malaise and difficulty swallowing. Polymyositis is associated with anti-Jo1 autoantibodies.

Systemic sclerosis, also known as diffuse scleroderma, is an autoimmune disease that primarily affects women aged 30-50. It causes collagen accumulation, leading to thickening of the skin and vasculitis affecting small arteries. Systemic sclerosis can affect multiple organ systems, including the skin, lungs, kidneys, and gastrointestinal tract. It is associated with anti-Scl70 antibodies.

Treatment Options for Severe Rheumatoid Arthritis

Severe rheumatoid arthritis can be a challenging condition to manage, especially when conventional disease-modifying anti-rheumatic drugs (DMARDs) fail to provide relief. In such cases, biological therapies may be recommended. Here are some treatment options for severe rheumatoid arthritis:

Enrol in Biological Therapy Programme
Patients with highly active disease despite trying three previous agents for a therapeutic treatment duration may be candidates for biological treatments. TNF-alpha inhibitors and anti-CD20 are examples of biological treatments that are routinely used in the UK.

Maintain on Steroids and Add a Bisphosphonate
Short-term treatment with glucocorticoids may be offered to manage flares in people with recent-onset or established disease. However, long-term treatment with glucocorticoids should only be continued when the long-term complications of glucocorticoid therapy have been fully discussed and all other treatment options have been offered.

Commence Leflunomide
Severe disease that has not responded to intensive therapy with a combination of conventional DMARDs should be treated with biological agents. Leflunomide is one of the DMARDs that can be used in combination therapy.

Use Methotrexate/Leflunomide Combination
Patients who have not responded to intensive DMARD therapy may be prescribed a biological agent, as per NICE guidelines. Methotrexate and leflunomide are two DMARDs that can be used in combination therapy.

Avoid Commencing Penicillamine
DMARD monotherapy is only recommended if combination DMARD therapy is not appropriate. Patients without contraindications to combination therapy should not be prescribed penicillamine.

Understanding the Diagnosis of Polymyalgia Rheumatica

Polymyalgia rheumatica (PMR) is a condition that causes pain and stiffness in proximal muscle groups, often accompanied by systemic symptoms. While other potential diagnoses such as infections or neoplasia should be considered, PMR is typically characterised by raised levels of inflammatory markers, particularly erythrocyte sedimentation rate (ESR). Treatment with corticosteroids usually results in rapid improvement, and lack of response to steroids may indicate a need to re-evaluate the diagnosis. Autoantibody screening and nerve conduction velocity tests are not helpful in diagnosing PMR, while muscle biopsy may be performed to exclude polymyositis. A temporal artery biopsy may be considered if the patient has symptoms of giant cell arthritis.

Behçet’s Syndrome: A Multisystem Disorder with Recurrent Oral and Genital Ulcerations

Behçet’s syndrome is a multisystem disorder that primarily affects young people from the Mediterranean region, the Middle East, and the Far East. The syndrome is characterized by recurrent oral and genital ulcerations, as well as ocular involvement. The main pathologic lesion is systemic perivasculitis with early neutrophil infiltration and endothelial swelling. In some patients, vasculitis of the vasa vasorum can result in the formation of pseudo-aneurysms. Anti-Saccharomyces cerevisiae antibodies are present in patients with Behçet’s syndrome. The recurrent aphthous ulcerations are essential for the diagnosis, and a non-specific skin inflammatory reactivity to any scratches or intradermal saline injection (pathergy test) is a common and specific manifestation. Genital ulcers are painful, do not affect the glans penis or urethra, and produce scrotal scars. Thromboembolic events are a component of the disease itself, with superficial or deep peripheral vein thrombosis seen in 30% of patients. Pulmonary emboli are a rare but possible complication.

Other possible diagnoses, such as extra intestinal Crohn’s disease, occult malignancy, systemic lupus erythematosus (SLE), and rheumatoid arthritis, can be ruled out based on the absence of certain clinical features and the presence of anti-Saccharomyces cerevisiae antibodies.

Medication Combinations for Treating Rheumatoid Arthritis

When treating rheumatoid arthritis, the first-line medication is a DMARD monotherapy with methotrexate. Short-term steroids may also be used in combination with DMARD monotherapy to induce remission. Hydroxychloroquine is another medication that can be used, but patients should be closely monitored for visual changes as retinopathy and corneal deposits are common side effects.

Etanercept is not a first-line treatment for rheumatoid arthritis, and methotrexate should not be given in combination with a TNF-alpha inhibitor like etanercept. Methotrexate plus sulfasalazine is an appropriate medication combination for treating rheumatoid arthritis, but regular eye checks are not required as neither medication affects vision.

If a patient has failed treatment with methotrexate, sulfasalazine plus hydroxychloroquine may be a regimen to consider trialling. However, it is important to note that new-onset rheumatoid arthritis should be treated with a DMARD monotherapy first line, with the addition of another DMARD like methotrexate as the first-line option.

Reactive Arthritis

Reactive arthritis is a medical condition that is typically characterized by a combination of three symptoms: urethritis, conjunctivitis, and seronegative arthritis. This type of arthritis usually affects the large weight-bearing joints, such as the knee and ankle, but not all three symptoms are always present in a patient. Reactive arthritis can be triggered by either a sexually transmitted infection or a dysenteric infection. One of the most notable signs of this condition is the appearance of a brown macular rash known as keratoderma blennorrhagica, which is usually seen on the palms and soles.

The main treatment for reactive arthritis involves the use of non-steroidal anti-inflammatory drugs (NSAIDs). These medications can help to alleviate the pain and inflammation associated with the condition. Additionally, antibiotics may be prescribed to individuals who have recently experienced a non-gonococcal venereal infection. This can help to reduce the likelihood of that person developing reactive arthritis. Overall, the symptoms and treatment options for reactive arthritis can help individuals to manage this condition and improve their quality of life.

Systemic lupus erythaematosus (SLE) is an autoimmune disease where the body produces autoantibodies against various antigens, leading to the formation of immune complexes that can deposit in different parts of the body, such as the kidneys. Symptoms of SLE include fatigue, joint pain, rash, and fever. Diagnosis of SLE requires the presence of at least four out of eleven criteria, including malar rash, discoid rash, photosensitivity, oral or nasopharyngeal ulceration, arthritis, serositis, renal disorder, CNS disorders, haematological disorders, positive immunology, and positive ANA. Anti-double-stranded DNA (dsDNA) antibody is highly specific for SLE but only positive in 60% of patients. Other antibodies, such as anti-La antibodies, rheumatoid factor IgG, ANCA, and Scl70, are raised in other autoimmune diseases such as Sjögren’s syndrome, rheumatoid arthritis, and various vasculitides.

Differentiating between Elevated Serum Markers in a Patient with Arthropathy and Hilar Lymphadenopathy

The presence of arthropathy and hilar lymphadenopathy in a patient can be indicative of various underlying conditions. In this case, the patient’s elevated serum markers can help differentiate between potential diagnoses.

Elevated serum angiotensin-converting enzyme (ACE) is a common finding in sarcoidosis, which is likely the cause of the patient’s symptoms. Bilateral hilar lymphadenopathy with or without pulmonary fibrosis is the most typical radiological sign of sarcoidosis. Additionally, acute arthropathy in sarcoidosis patients, known as Löfgren syndrome, is associated with erythema nodosum and fever.

On the other hand, elevated cytoplasmic anti-neutrophil cytoplasmic antibody (c-ANCA) is present in granulomatosis with polyangiitis (GPA), which presents with necrotising granulomatous lesions in the upper and lower respiratory tract and renal glomeruli. It is not typically associated with hilar lymphadenopathy.

Hyperuricaemia and elevated double-stranded (ds) DNA antibody are not relevant to this case, as they are not associated with the patient’s symptoms. Hyperglycaemia is also not a factor in this case.

In conclusion, the combination of arthropathy and hilar lymphadenopathy can be indicative of various underlying conditions. Elevated serum markers can help differentiate between potential diagnoses, such as sarcoidosis and GPA.

Differentiating Arthritides: Understanding Clinical and Laboratory Findings

Arthritis is a common condition that affects the joints, and it can be challenging to distinguish between the various types that exist. However, by considering the patient’s medical history, physical examination, and laboratory findings, clinicians can make an accurate diagnosis.

For instance, psoriatic arthritis is an inflammatory subtype of arthritis that often affects the DIP joints, sausage digits, and nails. The classic X-ray finding of psoriatic arthritis is the pencil in a cup appearance, although it is not specific to the disease. In contrast, rheumatoid arthritis is characterized by PIP and MCP joint involvement, wrist and cervical spine pain, and positive rheumatoid factor and anti-CCP antibodies.

Septic arthritis is a medical emergency that usually involves large joints and is associated with high fever, chills, and rapid joint destruction. Synovial fluid analysis may reveal Gram-positive cocci in cases of septic arthritis caused by Staphylococcus aureus.

Osteoarthritis, on the other hand, is a degenerative joint disease that is associated with subchondral cyst formation, joint space narrowing, and osteophyte formation. It typically affects the DIP and PIP joints and large weight-bearing joints, but it is not an inflammatory arthritis.

In summary, understanding the clinical and laboratory findings associated with different types of arthritis is crucial for accurate diagnosis and appropriate management.

Differentiating Types of Arthritis

Degenerative osteoarthritis is a condition that becomes more prevalent and symptomatic as one ages. It is characterized by the erosion and loss of articular cartilage. On the other hand, rheumatoid arthritis typically affects the small joints of the hands and feet, leading to marked joint deformity due to a destructive pannus. Gouty arthritis, on the other hand, is more likely to cause swelling and deformity with joint destruction, and the pain is not related to usage. Osteomyelitis, meanwhile, is an ongoing infection that produces marked bone deformity, not just joint narrowing. Lastly, Lyme disease produces a chronic arthritis, but it is typically preceded by a deer tick bite with a skin lesion. It is much less common than osteoarthritis. By the differences between these types of arthritis, proper diagnosis and treatment can be given to patients.

Differentiating Systemic Lupus Erythematosus from Other Connective Tissue Diseases

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can present with a variety of symptoms. Patients may experience pleuritic chest pain, arthralgia, and a typical rash, which are all indicative of SLE. Anti-nuclear antibodies are typically positive, although they are not specific to lupus. Treatment for SLE involves glucocorticoids as the mainstay, with second-line agents including cyclophosphamide, hydroxychloroquine, and azathioprine. BLyS inhibitors are also showing promise in clinical trials.

Other connective tissue diseases, such as granulomatosis with polyangiitis (GPA), rheumatoid arthritis, systemic sclerosis, and mixed connective tissue disease, have distinct features that differentiate them from SLE. GPA is a necrotising small-vessel vasculitis that commonly affects the kidneys and lungs, with palpable purpura on the extremities. Rheumatoid arthritis typically presents with joint pain and swelling, but without a butterfly rash or hypertension. Systemic sclerosis affects the skin on the face, forearms, and lower legs, with Raynaud’s, sclerodactyly, and telangiectasia. Mixed connective tissue disease has features of SLE, but without any other connective tissue disease symptoms.

It is important to differentiate between these diseases to provide appropriate treatment and management for patients.

Systemic lupus erythematosus (SLE) is an autoimmune disorder that predominantly affects young women. It is characterized by a photosensitive butterfly-shaped rash on the face and joint manifestations. Unlike rheumatoid arthritis, SLE does not cause severe destruction of joints. SLE is a multisystem condition that can affect many systems, including haematological, renal, respiratory, and cardiac systems. The underlying pathological mechanism of damage in SLE is immune complex deposition, which produces antibodies against several nuclear components of the body, especially against double-stranded DNA (dsDNA). Antinuclear antibodies (ANA) and dsDNA are associated with SLE, as is a low C3 and C4. The immunoglobulin, C3 and fibrinogen deposits found in this patient are classic of the immune complex deposition seen in SLE.

Osteoarthritis in the Hand and Elbow

Osteoarthritis (OA) is a prevalent form of arthritis that commonly affects the hand, particularly the joints. The joints may exhibit several deformities, including the development of small bone spurs called nodes. These nodes are referred to as Heberden’s nodes when they occur at the joint next to the fingernail and Bouchard’s nodes when they occur at the middle joints. The base of the thumb may also appear squared off, accompanied by swelling and tenderness. Soft tissue laxity can result in instability at the base of the thumb.

In contrast, elbow OA is relatively uncommon.

Differentiating between Rheumatic Diseases: A Case Study

Polymyalgia rheumatica (PMR) is a common inflammatory rheumatic disease in the elderly population, presenting as pain and stiffness in the neck, shoulders, upper arms, and hips. In contrast, polymyositis is an autoimmune connective tissue disease that results in proximal muscle weakness. Multiple myeloma is a malignancy of plasma cells, causing bone pain, renal failure, and anaemia. Rheumatoid arthritis is a chronic inflammatory, symmetrical polyarthropathy that tends to cause joint stiffness and pain within the small joints, as well as causing fatigue. Osteoarthritis is a degenerative arthritis that commonly affects the knee, hip, spine, and hands.

In this case study, the patient presented with shoulder stiffness, fatigue, low-grade fever, and anaemia. A diagnosis of PMR was made clinically and with the aid of a raised ESR. Treatment is with oral prednisolone, which should be reduced gradually once symptoms are controlled to avoid the risks of chronic steroid use.

It is important to differentiate between these rheumatic diseases as they have different underlying causes, presentations, and treatments. A thorough history, physical examination, and appropriate investigations are necessary for accurate diagnosis and management.